Lumiradx Healthcare Private Limited
Lumiradx Healthcare Private Limited is a Private Subsidiary of Foreign Company company incorporated in 2021 and based in Maharashtra, India. Lumiradx Healthcare Private Limited operates in Medical & Precision (NIC 33309) with authorized capital of ₹2.50 Cr and paid-up capital of ₹65.00 L. For 2023-24, the company reported revenue of ₹3.81 Cr and profit after tax of ₹50.06 L. The board has 2 active directors. RegisterKaro's provisional Compliance Health Score for the company is 100/100 (grade A), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
LUMIRADX HEALTHCARE PRIVATE LIMITED is the legal entity of LumiraDx.
Quick facts
Directors
2 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +27d | filed |
| MGT-7 | FY2024-25 | 27 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +10d | filed |
| MGT-7 | FY2023-24 | 21 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +16d | filed |
| MGT-7 | FY2022-23 | 24 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Lumiradx Healthcare Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 171808069 | State Bank of India(Bank) | ₹79.82 L | 12 Mar 2022 | Satisfied |
| 168060297 | HDFC Bank Ltd(Bank) | ₹16.67 Cr | 12 Mar 2020 | Satisfied |
| 151502835 | State Bank of India(Bank) | ₹19.87 Cr | 12 Mar 2020 | Open |
| 506175387 | State Bank of India(Bank) | ₹1.31 Cr | 27 Jan 2019 | Open |
| 583589573 | Kotak Mahindra Bank Ltd(Bank) | ₹7.77 Cr | 27 Jan 2023 | Open |
| 377629268 | Kotak Mahindra Bank Ltd(Bank) | ₹8.16 Cr | 27 Jan 2020 | Satisfied |
Charge IDs, lenders & amounts for Lumiradx Healthcare Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2023-24 | — | ||||
| 2021-22 | — |
Detailed Financials
2 FYs| Line item | 2023-24 | 2021-22 |
|---|---|---|
| Income statement | ||
| Revenue from operations | ||
| Other income | ||
| Total income | ||
| Total expenses | ||
| Profit before tax | ||
| Profit / (Loss) after tax | ||
| Balance sheet | ||
| Equity / Net worth | ||
| Borrowings | ||
| Current liabilities | ||
| Total liabilities | ||
| Current assets | ||
| Cash & equivalents | ||
| Total assets | ||
| Employees | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2023-24 | +710.0% | — | — | |
| Profit after Tax2023-24 | +914.0% | — | — | |
| Net Worth2023-24 | +13.0% | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2021-22 | +7.99% | — | +10.47% | +6.30% | 1.66 | |||
| 2023-24 | +13.14% | +300.71% | +35.87% | +23.45% | 1.53 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 31,36,565 | 61.46% |
| Institutional Investors | 3 | 5,42,909 | 10.64% |
| Public & Others | 25 | 14,23,946 | 27.90% |
Promoter, institutional & public holding for Lumiradx Healthcare Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
59 peersEvents & timeline
3External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.